Cedar scourge Pollen could be high this year due to weather

Published on:  September 1, 2025 Education

Cedar scourge Pollen could be high this year due to weather

By Robin Blackburn The Herald-Zeitung It’s a nemesis with many names, but when it strikes, it’s unmistakable. The pollen of the Ashe juniper tree – also known as cedar, mountain cedar, post cedar or juniper – is beginning its annual assault on Texans’ respiratory and immune systems.
This year’s cedar season —
which typically begins in December and ends in February– is forecast to be pretty severe, said Comal County Texas Agrilife Extension Agent Troy Luepke.
“There are very good chances we’re going to have a very bad cedar season this year just due to the weather we’ve had,” Luepke said.Temperatures and moisture have both been above normal, Luepke explained, and that means the Ashe juniper trees will be producing more pollen than average.
“If you think of it, it’s a kind of dust,” Dr. Jay L. Gruhlkey of Lonestar Medical said.
“When there’s enough of it, it can irritate even those who aren’t allergic. It’s tough on patients. It keeps us busy this time of year.”
Gruhlkey said that in 2014, Ashe juniper pollen counts were in the 20,000s, and when the pollen is that thick it’s hard to not feel the effects. It doesn’t help that the pollen is around for just a short period, he said. “Our immune system only sees cedar two months out of the year,”
Gruhlkey said, “so there’s not really a chance to develop a positive response.” Gruhlkey said that even though complete avoidance of Ashe juniper pollen is difficult, there are steps to take to limit exposure and thus lessen allergy symptoms and irritation.

An allergy testing kit is seen Tuesday, Dec. 6, 2016 in an exam room at Lonestar Medical.

 

“It’s hard to live in a bubble during cedar season,” he said. “But the cornerstone of allergy issues is avoidance, asmuch as you can.”

Gruhlkey recommended using good air filters, washing your skin and clothing after being outdoors, using filter masks when outdoors, and starting antihistamines and anti-inflammatory medicines early in the season.

“Starting medicines early is important,” he said. Gruhlkey also said nasal rinses can help wash pollen out of sinuses and can help with other seasonal sinus complaints.

“This time of year, we turn on the heaters, and the relative humidity goes down, and that can dry out your sinuses,” he said. “Nasal rinses can help keep the sinuses hydrated.”

For people who aren’t allergic but get irritated by the high volumes of pollen, Gruhlkey said, antihistamines wouldn’t be effective, but taking the same measures to lessen exposure to the pollen would help.

“Just like you would if you were working around dust – nasal rinses, masks and avoidance,” he said.

If left untreated, allergies and irritation can create more serious health problems, Gruhlkey said.

“Allergies create an inflammatory response that, if it stays around long enough, can evolve into a sinus infection,” he said.

That inflammation can also occur in the lungs, aggravating other breathing problems.

“Asthmatics especially want to keep their allergies in check,” he said.

If over-the-counter treatments and other preventive measures aren’t helping, Gruhlkey said, talk to your physician and see about getting tested for allergies and exploring other options.

Texans will need to learn to live alongside Ashe juniper trees for the long term; Luepke said the tree is here to stay, despite some eradication efforts.

“People are trying to reduce the number of trees on their property,” he said, “but we will never eliminate the Ashe juniper because of howprolific it is.”

Scroll to Top

Dr. Jay L. Gruhlkey is Co-Founder and Chief Medical Officer of Direct Allergy, LLC, and a practicing physician in New Braunfels, TX. Widely respected in Allergy and Immunology, he has served as Past-President of the Pan American Allergy Society and has trained thousands of doctors nationwide in allergy testing and treatment through the National Procedure Institute.

Dr. Gruhlkey began his medical career after earning a B.S. in Chemistry from Texas A&M University and an M.D. from The University of Texas Health Science Center–Houston. He completed his Family Medicine residency at Southwest Memorial Hospital, where he was Chief Resident. His contributions to medicine have been recognized with the Mead Johnson Award for Graduate Medical Education and the AMA Foundation Leadership Award. In addition to clinical practice, he consults on medical and legal matters and serves on several healthcare boards.

Robert Schultz is an accomplished executive, cross-industry leader, and market disruptor with over 3 decades of national award-winning achievements within both Field Sales & Field Sales Management across Fortune 100 companies and emerging healthcare ventures. With over 30 years of experience spanning two major industries—pharmaceuticals (ie. Johnson & Johnson, Eli Lilly, GSK-Reliant) and automotive manufacturing (Ford Motor Company)—Robert brings a unique, cross-disciplinary perspective to healthcare innovation.

Robert began his career in 1987 at Ford Motor Company’s World Headquarters and ended it in Cleveland, OH. He enjoyed four promotions in only four years’ time. He then transitioned to the pharmaceutical industry for a 2-decade cycle with heavy developmental movement with major players like Johnson & Johnson, Eli Lilly, GSK, and Daiichi-Sankyo. His roles included Regional Business Manager, Manager, Research & Consulting, District Sales Manager, Assoc. Manager, Managed Care Analyst, Assoc. Manager, Neuroscience & PCP Training & Development, Corporate Auditor, Managed Care.  In 2011, with the backing of Ben Franklin Technology Partners & his old employer’s Co-Founder (GSK-Reliant), Schultz co-founded and became CEO of Direct Allergy, LLC, where he has transformed a once-fragmented sector into a scalable, patient-focused allergy care platform geared for the large primary care health networks that are now housed within the large healthcare systems (IDNs) nationwide. He led the development and commercialization of the Direct Allergy (DA) service model, navigating regulatory hurdles, the pandemic-era, and the capital markets crisis.  The DA service model has been pressure tested across seven states and 52 + clinical sites, and the company is debt-free.  His commitment to strategic execution, academic collaboration, and community goodwill earned the company the Corporate Partner of the Year Award from Penn State University (Erie Campus) in 2021. Today, with the Black Swan events behind and proof of concept successfully complete, Robert, along with the Direct Allergy Board of Managers, have the company positioned for a positive transition for next level funding.